Hot Biotechs (fka HOTBIO)

[Ruellit]

DRUG - DD
This stock has been on a rollercoaster ride and it may not be over yet. Make sure to take a look at this chart!

Dragon Pharmaceutical Inc. is a development stage pharmaceutical and biotechnological company whose business plan is to develop, manufacture and market pharmaceutical products in China. Dragon's proprietary technology will allow it to produce drugs such as Erythropietin (EPO) in an efficient and cost-effective manner. Dragon's strategy is to use its biotechnological expertise to produce and market pharmaceutical products primarily in China through the acquisition of a manufacturing license and access to a production facility in China. To this end, Dragon acquired a 75% interest in Nanjing Huaxin, a pharmaceutical company and the largest domestic producer of Erythropoietin (EPO). Since the acquisition, Huaxin's facilities have been upgraded to increase the production yield and decrease the cost of production for EPO.
Financials
For the three months ended 3/31/01, sales increased less than 1% to $664 thousand. Net loss totaled $856 thousand, up from $235 thousand. Revenues reflect increased sales of EPO in China. Higher loss reflects increased production costs and higher depreciation and market development expenses.

Share Structure
16.7M OS
5.8 FLT
43.4M Market Cap
Book Value $0.79

Profile
http://finance.yahoo.com/q?s=drug.ob&d=t
Chart
http://www.askresearch.com/cgi-bin/chart?symbol=drug&country=USA
News
http://biz.yahoo.com/n/d/drug.ob.html

muel <ggg>